ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Montréal, QC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Montréal, QC, CAN:

Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer PAINT)

The goal of this clinical trial is to test the safety of the use of non-thermal plasma (NTP, an ionized gas) on the tumor bed after the remo ...

Not yet enrolling
Breast Cancer
Device: Convertible Plasma Jet
Centre hospitalier de l'Université de Montréal (CHUM)

Montréal, Quebec, Canada

DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...

Active, not recruiting
Metastatic Breast Cancer
Drug: Tucatinib
Drug: Durvalumab

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Montreal, Quebec, Canada and 71 other locations

The ZetaFuse™ Bone Graft is indicated for patients with destructive, lytic lesions due to metastatic breast cancer to bone, with or...

Enrolling
Metastatic Breast Cancer in the Spine
Device: ZetaFuse™ Bone Graft
Zetagen Therapeutics

Montréal, Quebec, Canada and 1 other location

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Montreal, Canada and 147 other locations

postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...

Active, not recruiting
Locally Advanced or Metastatic Breast Cancer
Drug: Lasofoxifene
Drug: Fulvestrant

Phase 2

Sermonix Pharmaceuticals

Montréal, Quebec, Canada and 50 other locations

The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-...

Enrolling
Metastatic Breast Cancer
Drug: Paclitaxel
Drug: Nab-paclitaxel

Phase 3

DualityBio

Montreal, Quebec, Canada and 126 other locations

to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...

Enrolling
Breast Cancer
Drug: vepdegestrant
Drug: Samuraciclib

Phase 1, Phase 2

Pfizer
Pfizer

Montréal, Quebec, Canada and 46 other locations

medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...

Enrolling
Breast Cancer
Drug: Abemaciclib
Drug: ARV-471

Phase 1, Phase 2

Pfizer
Pfizer

Montreal, Quebec, Canada and 44 other locations

medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...

Enrolling
Breast Cancer
Drug: ARV-471
Drug: Ribociclib

Phase 1, Phase 2

Pfizer
Pfizer

Montreal, Quebec, Canada and 44 other locations

in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple negative breast...

Active, not recruiting
Triple Negative Breast Neoplasms
Drug: Capivasertib
Drug: Trastuzumab deruxtecan

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Montreal, Quebec, Canada and 31 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems